4//SEC Filing
Clark Eliana 4
Accession 0000950170-24-002502
CIK 0001652130other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:44 PM ET
Size
6.4 KB
Accession
0000950170-24-002502
Insider Transaction Report
Form 4
Clark Eliana
EVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2024-01-03$29.46/sh−4,301$126,707→ 40,845 total - Sale
Common Stock
2024-01-03$30.12/sh−307$9,247→ 45,146 total
Footnotes (2)
- [F1]Sale of 307 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2023.
- [F2]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001914448
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:44 PM ET
- Size
- 6.4 KB